Garden State Investment Advisory Services’s CVS Health CVS Stock Holding History

Garden State Investment Advisory Services’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,906	Closed	-$311K	–	262
2024 Q1	$311K	Sell	3,906 -1	-0%	-$76	0.11%	169
2023 Q4	$308K	Sell	3,907 -193	-5%	-$13.7K	0.12%	155
2023 Q3	$286K	Buy	4,100 +111	+3%	+$7.87K	0.13%	139
2023 Q2	$276K	Buy	3,989 +562	+16%	+$40K	0.11%	152
2023 Q1	$255K	Sell	3,427 -543	-14%	-$45.5K	0.11%	155
2022 Q4	$370K	Buy	+3,970	New	+$383K	0.22%	104

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Garden State Investment Advisory Services's CVS Position: Q2 2024 in Review

Garden State Investment Advisory Services sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,906 shares — an estimated $311K sold.

Garden State Investment Advisory Services first reported a position in CVS in Q4 2022 and held it in 6 quarters. The position peaked at $370K in Q4 2022. 1,915 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Garden State Investment Advisory Services reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Garden State Investment Advisory Services sold 3,906 CVS Health shares in Q2 2024, an estimated $311K.
Garden State Investment Advisory Services first reported a position in CVS Health in Q4 2022 and held it in 6 quarters.
Garden State Investment Advisory Services's CVS Health position peaked at $370K in Q4 2022.
1,915 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Garden State Investment Advisory Services's 13F filing for Q2 2024, filed 13 Aug 2024.